期刊文献+

体外沉默血管内皮生长因子对D-(-)-MTX/A549耐药细胞株迁移侵袭能力的影响

Effects of silencing VEGF gene expression on migration and invasion of D-(-)-MTX/A549 resistance cells
下载PDF
导出
摘要 目的:研究血管内皮生长因子(vascular endothelial growth factor,VEGF)基因沉默对D-(-)-MTX/A549耐药细胞株迁移和侵袭的影响及可能的分子机制。方法:采用siRNA技术沉默D-(-)-MTX/A549耐药细胞株VEGF基因,细胞划痕试验和Transwell试验检测细胞迁移和侵袭能力,实时荧光定量PCR检测VEGF、MMP-2 mRNA,Western blot检测p-ERK1/2蛋白的表达。结果:VEGF siRNA序列及阴性对照成功转染至D-(-)-MTX/A549后,VEGF mRNA表达水平明显下降,与阴性对照相比下降了2.29倍,差异具有统计学意义(P=0.002),表明转染成功。阴性对照组与空白组差异无统计学意义(P>0.05)。转染后,D-(-)-MTX/A549迁移和侵袭能力明显下降(P值均<0.05),D-(-)-MTX/A549耐药细胞MMP-2 mRNA、p-ERK1/2的蛋白达也较阴性对照水平明显下降(P值均<0.05)。结论:抑制VEGF基因表达可以抑制D-(-)-MTX/A549细胞的迁移和侵袭能力,这一过程可能涉及到MMP-2和p-ERK1/2信号通路。 AIM: To study effects of silencing VEGF gene expression on migration and invasion of D-(-) -MTX/A549 resistance ceils. METHODS: VEGF siRNA was transfected to D-(-)-MTX/A549 resistance cells. Migration and invasion ablities were detected by scratch wound healing and transwell as- say respectively. The mRNA expression levels of VEGF and MMP-2 were examined by real-time fluo- rescent quantitative PCR. The protein expression level of p-ERK1/2 was detected by western blot a- nalysis. RESULTS:After VEGF siRNA and negative control were transfected to D- (-) - MTX/A549, VEGF mRNA expression level was decreased obvi- ously compared with negative control ( P = 0. 002 ),negative control and blank groups have no statistical significance (P 〉 0.05 ). D- (-) - MTX/A549 mi- gration and invasion ability significantly decreased (P 〈 0.05) ,MMP-2 mRNA and P-ERK1/2 protein levels were also significantly decreased after trans- fection (P 〈 0.05 ). CONCLUSION : Inhibition of VEGF expression can inhibit the D- (-) - MTX/ A549 cell migration and invasion ability, and this process may involve the MMP-2 and p-ERK1/2 sig- naling pathways.
出处 《中国临床药理学与治疗学》 CAS CSCD 2016年第7期745-748,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 安徽省高等学校省级自然科学研究基金(KJ2013B319) 皖南医学院重点科研项目培育基金项目(WK2013ZF04)
关键词 血管内皮生长因子 甲氨蝶呤 耐药 细胞迁移 细胞侵袭 vascular endothelial growth factor methotrexate resistance cell migration cell inva- sion
  • 相关文献

参考文献8

  • 1陶绍能,何晓东,董林,李明,朱园园,孙自敏,沈佐君.氨甲蝶呤对映体耐药A549细胞株的建立及其生物学特征[J].肿瘤防治研究,2009,36(4):273-277. 被引量:10
  • 2陶绍能,何晓东,沈佐君,董林.甲氨蝶呤对映体耐药A549细胞侵袭、转移能力的差异分析[J].中华医学杂志,2012,92(35):2509-2512. 被引量:1
  • 3董林,何晓东,陶绍能,孙余婕,李明,沈佐君.甲氨蝶呤对映体诱导的肺癌A549耐药细胞株中VEGF及其受体表达差异的研究[J].肿瘤,2009,29(5):404-408. 被引量:9
  • 4Wattanawongdon W, Hahnvajanawong C, Namwat N, et al. Establishment and characterization of gemcitabine- resistant human cholangiocarcinoma cell lines with muhidrug resistance and enhanced invasiveness [ J ]. Int J Oncol,2015,47( 1 ) : 398-410.
  • 5Karroum A, Mirshahi P, Benabbou N, et al. Matrix met- alloproteinase-9 is required for tubular network forma- tion and migration of resistant breast cancer cells MCF- 7 through PKC and ERK1/2 signalling pathways [ J ]. Cancer Lett,201 O, 295 (2) : 242-251.
  • 6Zhang P, Guo XS, Li J, et al. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signa- ling pathway in non-small cell lung cancer[ J ]. Onco- target, 2015, 6(15) : 13550-13563.
  • 7Yang Y, Bai Y, Xie G, et al. Efficient inhibition of non-small-cell lung cancer xenograft by systemic deliv- ery of plasmid-encoding short-hairpin RNA targeting VEGF [ J]. Cancer Biother Radiopharm, 2010, 25 (1) : 65-73.
  • 8Chung LY,Tang SJ, Sun GH, et al. Galectin-1 promotes lung cancer progression and chemoresistance by upreg- ulating p38 MAPK, ERK, and cyclooxygenase-2 [ J ]. Clin Cancer Res ,2012,18 ( 15 ) :4037-4047.

二级参考文献28

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部